Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Some companies, however, reported a market capitalisation decline, including Gilead Sciences and Roche.
Source: yahoo.com
Drugs Database News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Drugs Database. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Drugs Database Today - Breaking & Trending Today
GlobalData : TauRx's HMTM could become first oral DMT targeting Tau for Alzheimer's disease, says GlobalData -March 08, 2024 at 11:12 pm EST
08 Mar, 2024 TauRx's HMTM could become first oral DMT targeting Tau for Alzheimer's disease, says GlobalData Share Print...
Source: marketscreener.com
Otsuka's new formulations to offset Abilify Maintena dual patent expiry impact, says GlobalData
Otsuka Pharmaceutical is poised for a strategic transition as it approaches the loss of market exclusivity of Abilify Maintena (Aripiprazole) in Europe and the US in October 2024. This significant development signals a forthcoming shift in the drug’s sales trajectory, highlighting Otsuka’s readiness to embrace ...
Source: pharmiweb.com
11 - Policie České republiky
Popisky – chemie, zkoumání léků, anabolik, lihovin
Source: policie.cz
Top biopharma firms report Q3 market capitalisation decline
The top 20 biopharma companies averaged a market capitalisation decline of $3.45 trillion in Q2 to $3.14 trillion in Q3 2022, says GlobalData.
Source: europeanpharmaceuticalreview.com